Physician

Howard Charles, M.D.

According to 2025 Medicare claims, Howard Charles, M.D. (NPI: 1427078310) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is OPTUM MEDICAL CARE, P.C. (NPI: 1982643003; TIN: 133544120) and primary practice location at 10549-9998. Charles is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Charles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,068 traditional Medicare patients, billed 33,337 HCPCS/CPT codes, and received $2,977,695 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,548 prescription claims across 405 beneficiaries totaling $217,497 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 8 records totaling $527. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,074	16,540	$2,650,204
2016	2,196	18,263	$3,016,089
2017	2,278	18,558	$3,522,759
2018	2,274	19,395	$3,724,379
2019	2,276	19,058	$3,796,761
2020	2,016	16,378	$3,546,558
2021	2,130	17,060	$3,513,760
2022	2,150	17,646	$3,061,263
2023	2,054	25,323	$2,784,988
2024	2,068	33,337	$2,977,695

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	379	1,514	$196,814
2016	383	1,524	$211,338
2017	383	1,531	$253,029
2018	384	1,595	$244,279
2019	380	1,479	$246,203
2020	363	1,549	$254,027
2021	423	1,839	$302,952
2022	434	1,626	$265,275
2023	405	1,600	$271,902
2024	405	1,548	$217,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	325	2,070	$658
92014	Established patient complete exam of visual system	1,061	1,642	$102
67028	Injection of drug into eye	516	1,777	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,362	2,492	$76
92134	Imaging of retina	1,783	4,745	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	43	2,970	$61,313
Lumigan	Bimatoprost	38	1,980	$20,207
Xiidra	Lifitegrast	11	930	$19,876
Cyclosporine	Cyclosporine	27	1,890	$18,670
Combigan	Brimonidine Tartrate/Timolol	67	2,297	$14,936

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$527	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Howard Charles, M.D.?

Tedicare shows public-source Medicare data for Howard Charles, M.D. (NPI 1427078310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Howard Charles, M.D. have ACO affiliation data?

Howard Charles, M.D. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Howard Charles, M.D.?

Howard Charles, M.D. is linked to OPTUM MEDICAL CARE, P.C. (billing NPI 1982643003) in the available physician profile data.

Does Howard Charles, M.D. have Open Payments data?

Howard Charles, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.